HP - haptoglobin Gene
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 397061
HP Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_214000.2 | NP_999165.1 | haptoglobin precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
haptoglobin |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-101588 | Gefapixant | Antagonist | 99.93% | Yes |
| HY-17410 | Iloperidone | Antagonist | 99.93% | Unkown |
| HY-101588A | Gefapixant citrate | Antagonist | 99.23% | Unkown |
| HY-17410A | Iloperidone hydrochloride | Antagonist | / | Unkown |
Clinical Phase
Bioactive Molecules
(8)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-101103 | HP-β-CD | 99.74% | Phase 3 | |
| HY-127165 | Velnacrine | Inhibitor | 98.79% | Phase 3 |
| HY-W011246 | Velnacrine maleate | Inhibitor | 98.0% | Phase 3 |
| HY-123857 | JNJ-55308942 | Antagonist | 99.92% | Phase 2 |
| HY-117508 | JNJ-54175446 | Antagonist | 98.84% | Phase 2 |
| HY-135427 | Quilostigmine | Inhibitor | / | Phase 2 |
| HY-W050088 | Isoxepac | 99.97% | Phase 1 | |
| HY-P4669 | LM-030 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(70)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-114364 | UDP-Galactose disodium | Agonist | 99.73% | Unkown |
| HY-136026 | Camlipixant | Antagonist | 99.76% | Unkown |
| HY-15568 | A-317491 | Antagonist | 98.64% | Unkown |
| HY-151480 | HP590 | 98.02% | Unkown | |
| HY-110329 | ML179 | Agonist | 99.73% | Unkown |
| HY-15568A | A-317491 sodium salt hydrate | Antagonist | 99.88% | Unkown |
| HY-154840 | 4-Thiouridine 5′-triphosphate tetralithium | Agonist | 87.53% | Unkown |
| HY-E70058 | α-1-3,4 Fucosyltransferase, helicobacter pylori | 90.00% | Unkown | |
| HY-P1397A | RVD-Hpα TFA | Agonist | 98.92% | Unkown |
| HY-114364S | UDP-α-D-Galactose-13C disodium | 99% | Unkown | |
| HY-121870 | Dimethocaine | Substrate | 99.90% | Unkown |
| HY-146564 | R-HP210 | 98.21% | Unkown | |
| HY-146564A | HP210 | Modulator | 98.96% | Unkown |
| HY-P5310 | IgA1 Peptide HP | 99.89% | Unkown | |
| HY-127165S2 | Velnacrine-d4 hydrochloride | 98.60% | Unkown | |
| HY-127165S | Velnacrine-d3 | / | Unkown | |
| HY-17410S | Iloperidone-d3 | Antagonist | 98.8% | Unkown |
| HY-105463 | Saptomycin D | Inhibitor | / | Unkown |
| HY-106508 | Fendosal | Inhibitor | 99.82% | Unkown |
| HY-108654 | PSB 0474 | / | Unkown | |
| HY-127165S1 | Velnacrine-d3 maleate | / | Unkown | |
| HY-127165S3 | Velnacrine-d4 | / | Unkown | |
| HY-136092 | Androsta-1,4,6-triene-3,17-dione | Inhibitor | 95.0% | Unkown |
| HY-143576 | P2X3 antagonist 37 | Antagonist | / | Unkown |
| HY-145690 | HP1328 | Inhibitor | / | Unkown |
| HY-145691 | HP1142 | Inhibitor | / | Unkown |
| HY-146561 | S-HP210 | Modulator | 98.12% | Unkown |
| HY-150524 | UDP-Galactose | Agonist | / | Unkown |
| HY-153710 | P2X3 antagonist 38 | Antagonist | / | Unkown |
| HY-15376 | Besipirdine | Antagonist | / | Unkown |
| HY-156203 | MRS4608 | Antagonist | / | Unkown |
| HY-156220 | MRS4654 | Inhibitor | / | Unkown |
| HY-167855 | MRS4833 | Antagonist | / | Unkown |
| HY-167855S | 1’-Epi Gemcitabine hydrochloride-13C,15N2 | / | Unkown | |
| HY-170598 | HP211206 | Inhibitor | / | Unkown |
| HY-17410S1 | Iloperidone-d3 hydrochloride | Antagonist | / | Unkown |
| HY-175196 | P2X7 receptor antagonist-6 | Antagonist | / | Unkown |
| HY-175729 | Cyclin A/B RxL-IN-1 | Inhibitor | / | Unkown |
| HY-178006 | MRS4917 | Antagonist | / | Unkown |
| HY-178461 | LDHA-IN-10 | Inhibitor | / | Unkown |
| HY-179373 | UB-MBX-46 | Antagonist | / | Unkown |
| HY-179446 | HP1-IN-2 | Inhibitor | / | Unkown |
| HY-B2085 | Arsthinenol | Inhibitor | / | Unkown |
| HY-E70064A | Helicobacter pylori alpha-1,3-fucosyltransferase | / | Unkown | |
| HY-NP0236 | Cynomolgus Monkey haptoglobin | / | Unkown | |
| HY-NP226 | Helicobacter pylori protein | / | Unkown | |
| HY-P10539 | Hp1404 | Inhibitor | / | Unkown |
| HY-P11151 | HPA3NT3-A2 | Inhibitor | / | Unkown |
| HY-P1397 | RVD-Hpα | Agonist | / | Unkown |
| HY-RS03793 | DLC1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS06124 | HEPH Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS06331 | HP Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS06332 | HP1BP3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS06343 | HPR Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W011246S | Velnacrine-d3-1 maleate | / | Unkown | |
| HY-W050088S | Isoxepac-d6 | / | Unkown | |
| HY-106016 | HP 184 | Activator | / | Unkown |
| HY-14607 | Besipirdine hydrochloride | Inhibitor | / | Unkown |
| HY-154840A | 4-Thiouridine 5′-triphosphate tetrasodium | Agonist | / | Unkown |
| HY-168117 | HP-101 | Inhibitor | / | Unkown |
| HY-170599 | H117 | Inhibitor | 99.27% | Unkown |
| HY-170600 | Boc-Ala(Me)-H117 | / | Unkown | |
| HY-171951 | 31hP | / | Unkown | |
| HY-17410S2 | Iloperidone-13C,d3 | Antagonist | / | Unkown |
| HY-RS16740 | Hp Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS18035 | Heph Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS19126 | Dlc1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23177 | Hp Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W097612 | P2X4 antagonist-5 | Control | 99.14% | Unkown |
| HY-108668 | TC-P 262 | Inhibitor | / | Unkown |